Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12612000818831
Ethics application status
Approved
Date submitted
30/07/2012
Date registered
3/08/2012
Date last updated
23/11/2018
Date data sharing statement initially provided
23/11/2018
Type of registration
Retrospectively registered

Titles & IDs
Public title
The effects of increasing physical activity and reducing sedentary time in healthy, sedentary workers.
Scientific title
The effects of increasing physical activity and reducing sedentary time in healthy, sedentary workers.
Secondary ID [1] 280926 0
Nil
Universal Trial Number (UTN)
Nil
Trial acronym
Be Active @ Work
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Type 2 diabetes 287015 0
Overweight/obesity 287018 0
Condition category
Condition code
Metabolic and Endocrine 287347 287347 0 0
Diabetes
Cardiovascular 287348 287348 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
This study involves a two-arm parallel group randomised trial conducted over 9 months. The study involves attendance by both the gym-based exercise only group as well as the sedentary behaviour reduction group in three, one hour exercise sessions (which combine aerobic and resistance training) per week for three months.

The gym sessions run on non-consecutive days, two sessions are resistance based-exercises complimented with a cardio component. The third day comprises cardio only.

There are three (4 week) phases of the resistance training which allow for progression over time, promoting enhanced stimulus for strength and cardiovascular gains through increasing sets and weight. These three phases involve 6 strength training exercises, phase one is machine-based basic exercises, phase two encompasses bar-bell exercises, phase three increases variables
Cardio-based exercises may be performed on the participants choice of machine: bike, rowing machine, arm ergo, cross-trainer and treadmill.

The participants are guided through their new program at the introduction of each phase by qualified staff members - technique is supervised throughout each session to ensure safety and correct technique.

The intervention condition will undertake gymnasium-based exercise and sedentary behaviour reduction intervention which provides guidance and support to reduce their sedentary time during the day at work and increase their number of breaks in sedentary time (ie: changing from sitting to standing). This behavioural intervention was provided in the form of e-mails, phones calls and face to face consultations regarding behaviour change.

Post the 3 month intervention phase, participants continue to have access to the gym facilities for exercise. They are offered progression exercises by supervising staff. Attendance is monitored by staff members during the set opening hours of the gym.
Intervention code [1] 285360 0
Behaviour
Intervention code [2] 285391 0
Treatment: Other
Intervention code [3] 285392 0
Prevention
Comparator / control treatment
The gymnasium-based exercise group has acted as the control condition and involves participating in the gymnasium-based exercise only.
Control group
Active

Outcomes
Primary outcome [1] 287616 0
Metabolic measures were obtained by a registered nurse who performed venepuncture on the participants. Fasting blood glucose, insulin and lipids were processed by Alfred Pathology.
Timepoint [1] 287616 0
Conducted at baseline, at 3 months and 6 months post intervention.
Primary outcome [2] 287617 0
Anthropometrics were assessed; this included resting blood pressure, resting pulse rate obtained by a sphygmomanometer. Height was collected through the use of a Livingstone mounted tape measure. Weight was also collected using a calibrated set of weighing scales and waist and hip circumference collected using a standard tape measure. From these measures, BMI and hip to waist ratio were calculated by a syntax devised by the data analyst through SPSS version 17.0.
Timepoint [2] 287617 0
Conducted at baseline, at 3 months and 6 months post intervention.
Primary outcome [3] 287618 0
Physical activity: Sedentary behaviour and physical activity time were assessed in the study using accelerometers (Actigraph model GT3Xplus)and inclinometers (model activPAL). An activity diary will be used in combination with the two devices to allow participants to record when they put on/took off the devices or engaged in non- ambulatory physical activities (ie. cycling, swimming) that are not able to be recorded by the accelerometer. Participants will also enter work start/finish times in the diary on those work days the devices are worn.
Timepoint [3] 287618 0
The accelerometer and inclinometer will be worn for seven consecutive days at baseline and the last week of the intervention phase (Week 12). Participants will also be required to wear the devices for for five days (three workdays and two non-workdays) during week 5 and week 8 of the intervention phase

At the completion of the six month maintenance phase, participants wore and will wear the accelerometer and inclinometer again for seven consecutive days.
Secondary outcome [1] 298541 0
Work productivity has been assessed through the employment of an inhouse self-reported health and work questionnaire. This questionnaire is comprised of the health and work questionnaire, the ARROL, CES_D questionnaires, the Edinburgh Claudication Scale as well as the Sf12. A Dietary questionnaire is also included (DQESv2). This eludes to data reflecting general and mental health.
Timepoint [1] 298541 0
Conducted at baseline, at 3 months and 6 months post intervention.
Secondary outcome [2] 298543 0
Exercise compliance has been attained through an attendance spreadsheet reflecting the time of data and frequency of attendance for each participant. Each staff member supervising the running of the gym sessions monitors and takes note of who attends the open times.
Timepoint [2] 298543 0
Attendance to gym sessions will and have been monitored by staff members over 6 months following the 3 month intervention phase.

Eligibility
Key inclusion criteria
Participants will include full-time Baker IDI staff (men and women), aged 20-65 years with a BMI less than 40 kg/m2 who are characterised as being typically sedentary (sit at work for greater than or equal to 4 hours per day and watch television greater than or equal to 2 hours per day.
Minimum age
20 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
Not physically active (engage in less than 150 minutes/wk of moderate-to-vigorous physical activity), not on glucose, blood pressure or lipid lowering medications, not pregnant and otherwise healthy

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Participants were recruited by electronic advertisements circulated to all Baker IDI staff via email and through advertisements listed on the Baker IDI staff intranet.
Willing volunteers will be screened for eligibility via a telephone-administered interview with the research coordinator. During the interview, the research coordinator will explain the study details in lay terms and outline the inclusion/exclusion criteria. The research coordinator will also explicitly state that participation in the study is entirely voluntary and that participants may withdraw at anytime without pressure or cohesion. If the participant is suitable and willing to take part, a copy of the plain language statement will be forwarded to them by email.

Allocation concealment was executed by central randomisation using the computer. Using unidentifiable data to allocate each participant into either groups.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The participants were block randomised stratified by age, gender and BMI.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Two arm parallel study with a 6 month maintenance phase at the conclusion of the 3 month intervention phase.
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
16/06/2011
Actual
30/11/2011
Date of last participant enrolment
Anticipated
Actual
30/11/2012
Date of last data collection
Anticipated
Actual
30/11/2013
Sample size
Target
68
Accrual to date
Final
25
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 285710 0
Charities/Societies/Foundations
Name [1] 285710 0
Baker IDI Heart and Diabetes Institute
Country [1] 285710 0
Australia
Primary sponsor type
Charities/Societies/Foundations
Name
Baker IDI Heart and Diabetes Institute
Address
75 Commercial Road, Melbourne, VIC 3004
(Postal address: PO Box 6492, St Kilda Road Central VIC 3008)
Country
Australia
Secondary sponsor category [1] 284540 0
None
Name [1] 284540 0
Address [1] 284540 0
Country [1] 284540 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 287717 0
The Alfred Human Research Ethics Committee
Ethics committee address [1] 287717 0
Ethics committee country [1] 287717 0
Australia
Date submitted for ethics approval [1] 287717 0
16/12/2010
Approval date [1] 287717 0
07/01/2011
Ethics approval number [1] 287717 0
1/10/0382

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 34497 0
Prof David Dunstan
Address 34497 0
Baker Heart and Diabetes Institute
Level 4, 99 Commercial Road
Melbourne
VIC 3004
Country 34497 0
Australia
Phone 34497 0
+6138532111
Fax 34497 0
Email 34497 0
[email protected]
Contact person for public queries
Name 17744 0
Associate Professor David Dunstan
Address 17744 0
Baker IDI Heart and Diabetes Institute
Alfred Centre, Level 4 99 Commercial Road,
Melbourne, Victoria 3004
Country 17744 0
Australia
Phone 17744 0
+61 3 8532 1873
Fax 17744 0
Email 17744 0
[email protected]
Contact person for scientific queries
Name 8672 0
Alicia Thorp
Address 8672 0
Baker IDI Heart and Diabetes Institute
Alfred Centre, Level 4 99 Commercial Road,
Melbourne, Victoria 3004
Country 8672 0
Australia
Phone 8672 0
+61 3 8532 1854
Fax 8672 0
Email 8672 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.